These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24110993)

  • 1. In silico oncology: exploiting clinical studies to clinically adapt and validate multiscale oncosimulators.
    Stamatakos GS; Kolokotroni E; Dionysiou D; Veith C; Kim YJ; Franz A; Marias K; Sabczynski J; Bohle R; Graf N
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():5545-9. PubMed ID: 24110993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The technologically integrated oncosimulator: combining multiscale cancer modeling with information technology in the in silico oncology context.
    Stamatakos G; Dionysiou D; Lunzer A; Belleman R; Kolokotroni E; Georgiadi E; Erdt M; Pukacki J; Rüeping S; Giatili S; d'Onofrio A; Sfakianakis S; Marias K; Desmedt C; Tsiknakis M; Graf N
    IEEE J Biomed Health Inform; 2014 May; 18(3):840-54. PubMed ID: 24108720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: Mimicking a clinical study.
    Stamatakos GS; Kolokotroni EA; Dionysiou DD; Georgiadi ECh; Desmedt C
    J Theor Biol; 2010 Sep; 266(1):124-39. PubMed ID: 20515697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model.
    Stamatakos GS; Georgiadi EC; Graf N; Kolokotroni EA; Dionysiou DD
    PLoS One; 2011 Mar; 6(3):e17594. PubMed ID: 21407827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'In silico' oncology for clinical decision making in the context of nephroblastoma.
    Graf N; Hoppe A; Georgiadi E; Belleman R; Desmedt C; Dionysiou D; Erdt M; Jacques J; Kolokotroni E; Lunzer A; Tsiknakis M; Stamatakos G
    Klin Padiatr; 2009; 221(3):141-9. PubMed ID: 19437361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "Oncosimulator": a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology.
    Stamatakos GS; Dionysiou DD; Graf NM; Sofra NA; Desmedt C; Hoppe A; Uzunoglu NK; Tsiknakis M
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():6629-32. PubMed ID: 18003545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What does not kill a tumour may make it stronger: In silico insights into chemotherapeutic drug resistance.
    Hamis S; Nithiarasu P; Powathil GG
    J Theor Biol; 2018 Oct; 454():253-267. PubMed ID: 29909142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards in silico oncology: adapting a four dimensional nephroblastoma treatment model to a clinical trial case based on multi-method sensitivity analysis.
    Georgiadi ECh; Dionysiou DD; Graf N; Stamatakos GS
    Comput Biol Med; 2012 Nov; 42(11):1064-78. PubMed ID: 23063290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of hypermatrix and operator notation into a discrete mathematics simulation model of malignant tumour response to therapeutic schemes in vivo. Some operator properties.
    Stamatakos GS; Dionysiou DD
    Cancer Inform; 2009 Oct; 7():239-51. PubMed ID: 20011462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the predictability of acute lymphoblastic leukaemia response to treatment using a hybrid oncosimulator.
    Ouzounoglou E; Kolokotroni E; Stanulla M; Stamatakos GS
    Interface Focus; 2018 Feb; 8(1):20160163. PubMed ID: 29285342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiscale modeling of the dynamic growth of cancerous tumors under the influence of chemotherapy drugs.
    Farjami E; Mahjoob M
    Comput Methods Biomech Biomed Engin; 2024 Jun; 27(8):919-930. PubMed ID: 37227061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Numerical Handling of the Boundary Conditions Imposed by the Skull on an Inhomogeneous Diffusion-Reaction Model of Glioblastoma Invasion Into the Brain: Clinical Validation Aspects.
    Stamatakos GS; Giatili SG
    Cancer Inform; 2017; 16():1176935116684824. PubMed ID: 28469383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capturing the Dynamics of a Hybrid Multiscale Cancer Model with a Continuum Model.
    Joshi TV; Avitabile D; Owen MR
    Bull Math Biol; 2018 Jun; 80(6):1435-1475. PubMed ID: 29549576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid multiscale modeling and prediction of cancer cell behavior.
    Zangooei MH; Habibi J
    PLoS One; 2017; 12(8):e0183810. PubMed ID: 28846712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells.
    Barbarossa MV; Kuttler C; Zinsl J
    Math Biosci Eng; 2012 Apr; 9(2):241-57. PubMed ID: 22901063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Clinical Outcomes in Prostate Cancer: Application and Validation of the Discrete Event Simulation Approach.
    Pan F; Reifsnider O; Zheng Y; Proskorovsky I; Li T; He J; Sorensen SV
    Value Health; 2018 Apr; 21(4):416-422. PubMed ID: 29680098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis.
    Matsuo Y; Park JH; Miyamoto T; Yamamoto S; Hisada S; Alachkar H; Nakamura Y
    Sci Transl Med; 2014 Oct; 6(259):259ra145. PubMed ID: 25338756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents.
    Ribba B; Saut O; Colin T; Bresch D; Grenier E; Boissel JP
    J Theor Biol; 2006 Dec; 243(4):532-41. PubMed ID: 16930628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating and determining the effect of a therapy on tumor dynamics by means of a modified Gompertz diffusion process.
    Albano G; Giorno V; Román-Román P; Román-Román S; Torres-Ruiz F
    J Theor Biol; 2015 Jan; 364():206-19. PubMed ID: 25242298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of biguanides to improve response to chemotherapy.
    Sandulache VC; Yang L; Skinner HD
    Methods Mol Biol; 2014; 1165():3-9. PubMed ID: 24839014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.